Regulation A · Tier 2
Balanced Pharma Inc
Balanced Pharma Inc filed a Tier 2 Regulation A offering statement (Form 1-A) on Mar 21, 2022 for up to $25M at $4.00 per security. The SEC qualified the offering on Apr 8, 2022. Underwriter or broker: D, a and l.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $25M
- Offer price
- $4.00
- Security type
- Equity (common or preferred stock)
- Filed
- Mar 21, 2022
- Qualified
- Apr 8, 2022
- Industry
- Pharmaceutical Preparations
- State
- NC
- Underwriter / broker
- D, a, l, m, o, r, e, G, u, p, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Amount raised, from the exit report (Form 1-Z)
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other qualified Biotech & pharma Reg A offerings
- Aeris Biotechnologies, Inc.Jul 26, 2022 · $15M
- BioLIfe Sciences IncJun 30, 2022 · $20M
- Bioadaptives, Inc.May 11, 2022 · $1.5M
- Sibannac, Inc.Feb 7, 2022 · $9.4M
- Aibotics, Inc.Jan 18, 2022 · $15M
- Gelstat CorpDec 17, 2021 · $5M